clofibric acid has been researched along with E coli Infections in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Excerpt | Relevance | Reference |
---|---|---|
"Clofibric acid (CL) is a compound used to control hypertriglyceridemia, and ethacrynic acid (ET) is administered to enhance diuresis." | 1.33 | Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli. ( Balagué, C; De Duffard, AM; De Ruiz, CS; Duffard, R; Nader-Macías, ME; Rey, R; Stürtz, N, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balagué, CE | 1 |
de Ruiz, CS | 2 |
Rey, R | 2 |
de Duffard, AM | 2 |
Nader-Macías, ME | 2 |
Balagué, C | 1 |
Stürtz, N | 1 |
Duffard, R | 1 |
2 other studies available for clofibric acid and E coli Infections
Article | Year |
---|---|
Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Adhesion; Clofibric Acid; Escherich | 2004 |
Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Clofibric Acid; Disease Models, Animal; Diuretics; Drug Int | 2006 |